Literature DB >> 8295176

Fractures in rheumatoid arthritis: an evaluation of associated risk factors.

B A Michel1, D A Bloch, F Wolfe, J F Fries.   

Abstract

OBJECTIVE: Our purpose was to identify factors indicative of a high fracture risk during the disease course of rheumatoid arthritis (RA).
METHODS: In 1110 patients (879 women and 231 men) with RA from five Arthritis, Rheumatism and Aging Medical Information System centers, information from history, clinical and laboratory examination, outcome assessment, and therapy was evaluated for association with the 226 first fractures having occurred during the years from 1975 to 1988.
RESULTS: The mean age of the patients was 54 years, the mean time of observation was 8 years. Multivariate analyses identified the following factors to be associated with fracturing: years taking prednisone, previous diagnosis of osteoporosis, disability, age, lack of physical activity, female sex, disease duration, impaired grip strength, and low body mass.
CONCLUSION: We conclude that patients with RA at greatest risk for fracturing are easily identified by using a few clinical variables. These findings support encouragement of active lifestyle habits and avoidance of longterm administration of corticosteroids in patients with RA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295176

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

Review 1.  Assessment of fracture risk.

Authors:  Sanford Baim; William D Leslie
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  [Antiosteoporosis medication: useful monitoring, and how long should such treatment be continued?].

Authors:  W Demary
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372

Review 3.  [Particular features of steroid-induced osteoporosis].

Authors:  G E Hein
Journal:  Orthopade       Date:  2007-08       Impact factor: 1.087

4.  [Value of fall-risk tests for patients with rheumatoid arthritis].

Authors:  H-C Schober; K Maass; C Maass; E C Reisinger; G Schröder; C Kneitz
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

5.  Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  S Jin; E Hsieh; L Peng; C Yu; Y Wang; C Wu; Q Wang; M Li; X Zeng
Journal:  Osteoporos Int       Date:  2018-03-15       Impact factor: 4.507

6.  Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency.

Authors:  Anne Bachelot; Zeina Chakhtoura; Dinane Samara-Boustani; Jérome Dulon; Philippe Touraine; Michel Polak
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-28

Review 7.  [Bone densitometry in inflammatory rheumatic diseases : Characteristics of the measurement site and disease-specific factors].

Authors:  H Franck; J Braun; F Buttgereit; W Demary; G Hein; J Kekow; G Schett; P M Kern
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

8.  Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables.

Authors:  R E Ørstavik; G Haugeberg; T Uhlig; P Mowinckel; J A Falch; J I Halse; T K Kvien
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 9.  Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies.

Authors:  R N J de Nijs; J W G Jacobs; A Algra; W F Lems; J W J Bijlsma
Journal:  Osteoporos Int       Date:  2004-05-07       Impact factor: 4.507

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.